Login or sign up
For business
Average ratingGreat
4.3/ 5

Based on 8 reviews

550%
425%
325%
20%
10%
Ask AI

Ask Trustburn about BioDetego

Based on 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Michael McLelland
Reviews 1

BioDetego is an amazing company! I had a great experience working with them. The team is highly professional and dedicated. Their products are of top-notch quality and have helped our business greatly. I would highly recommend BioDetego to anyone in need of their services. They are simply outstanding!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About BioDetego

BioDetego is developing, VASPfore, a new biomarker test for selecting cancer treatment protocols. The VASP marker provides information that will direct chemotherapy to high risk patients who will likely benefit from treatment while preventing costly and harmful treatment of low risk patients. BioDetego predicts that the VASPfore will provide payors enormous savings (>$150MM/year) by reducing total treatment costs.

The company is led by David Zuzga, Ph.D., Founder and CEO, a research scientist with expertise in cell and molecular biology at La Salle University & Giovanni M. Pitari, M.D., Ph.D. Founder and CSO, a physician and research scientist with expertise in Translational Oncology.